Publication: Results from HARMONY: an open-label, multicentre, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis
| dc.contributor.author | Durrant, Simon T | |
| dc.contributor.author | Nagler, Arnon | |
| dc.contributor.author | Guglielmelli, Paola | |
| dc.contributor.author | Lavie, David | |
| dc.contributor.author | le Coutre, Philipp | |
| dc.contributor.author | Gisslinger, Heinz | |
| dc.contributor.author | Chuah, Charles | |
| dc.contributor.author | Maffioli, Margherita | |
| dc.contributor.author | Bharathy, Savita | |
| dc.contributor.author | Dong, Tuochuan | |
| dc.contributor.author | Wroclawska, Monika | |
| dc.contributor.author | Martinez-Lopez, Joaquin | |
| dc.date.accessioned | 2019-09-10T11:41:10Z | |
| dc.date.available | 2019-09-10T11:41:10Z | |
| dc.date.issued | 2019-05-09 | |
| dc.description.peerreviewed | Sí | es_ES |
| dc.format.page | haematol.2018.209965 | es_ES |
| dc.identifier.citation | Haematologica. 2019 May 9. [Epub ahead of print] | es_ES |
| dc.identifier.doi | 10.3324/haematol.2018.209965 | es_ES |
| dc.identifier.e-issn | 1592-8721 | es_ES |
| dc.identifier.issn | 0390-6078 | es_ES |
| dc.identifier.journal | Haematologica | es_ES |
| dc.identifier.pubmedID | 31073072 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/8323 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Fondazione Ferrata Storti | |
| dc.relation.publisherversion | https://doi.org/10.3324/haematol.2018.209965. | es_ES |
| dc.repisalud.institucion | CNIO | es_ES |
| dc.repisalud.orgCNIO | CNIO::Unidades técnicas::Unidad de Investigación Clínica de Tumores Hematológicos H12O-CNIO | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
| dc.subject | JAK inhibitor | es_ES |
| dc.subject | Myelofibrosis | es_ES |
| dc.subject | Ruxolitinib | es_ES |
| dc.title | Results from HARMONY: an open-label, multicentre, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 9b25aa8e-597b-43e0-90d0-6d3846974c12 | |
| relation.isAuthorOfPublication.latestForDiscovery | 9b25aa8e-597b-43e0-90d0-6d3846974c12 | |
| relation.isPublisherOfPublication | 4ae9ad58-4b15-4ba9-a50a-f7afd08836fe | |
| relation.isPublisherOfPublication.latestForDiscovery | 4ae9ad58-4b15-4ba9-a50a-f7afd08836fe |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ResultsfromHARMONYanopen-label_2019.pdf
- Size:
- 648.37 KB
- Format:
- Adobe Portable Document Format
- Description:


